Histomorphometric analysis of cutaneous remodeling in the early stage of the scleroderma model

Clinics

Volumn 64, Issue 6, 2009, Pages 577-583

  de Oliveira, Cristiane Carla ^a   Velosa, Ana Paula Pereira ^a   Parra, Edwin Roger ^a   Capelozzi, Vera Luiza ^a   Teodoro, Walcy Rosolia ^a   Yoshinari, Natalino Hajime ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Autoimmunity; Rabbits; Skin remodeling; Systemic sclerosis; Type V collagen

Indexed keywords

COLLAGEN TYPE 5; FREUND ADJUVANT;

ANIMAL; ARTICLE; BIOPSY; DISEASE MODEL; FEMALE; IMMUNOLOGY; PATHOLOGY; RABBIT; SKIN; SYSTEMIC SCLEROSIS;

ANIMALS; BIOPSY; COLLAGEN TYPE V; DISEASE MODELS, ANIMAL; FEMALE; FREUND'S ADJUVANT; RABBITS; SCLERODERMA, SYSTEMIC; SKIN;

EID: 68949111655     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322009000600014     Document Type: Article

References (23)

1. Black CM, Stephens C. Systemic sclerosis (scleroderma) and related disorders. In: Maddison PJ, Isenberg DA, Woo P, Glass DN. Textbook of Rheumatology. ed. Oxford: Oxford University Press; 1993. pp. 771-89.
2. Derk CT, Jimenez SA. Systemic sclerosis: current views of its pathogenesis. Autoimmunity Rev. 2003;2:181-91.
3. Varga J, Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Investigation. 2007;11:557-67.
4. Poole JL, Steen VD. The use of the health assessment questionnaire (HAQ) to determine physical disability in systemic sclerosis. Arthritis Care Res. 1991;4:27-31.
5. Clements PJ, Wong WK, Hurwitz EL, Furst DE, Mayes M, White B, et al. Correlates of disability index of health assessment questionaire: a measure of functional impairment in systemic sclerosis. Arthritis Rheum. 1999;42:2372-80.
6. Clements PJ, Hurwitz EL, Wong WK, Seibold JR, Mayes M, White B, et al. Skin thickness as a predictor and correlate of outcome in systemic sclerosis. High Dose versus low dose penicillamine trial. Arthritis Rheum. 2000;43:2445-54.
7. Le Roy EC. Increased collagen synthesis by scleroderma fibroblasts in vitro. A possible defect in the regulation or activation of the scleroderma fibroblasts. J Clin Invest. 1974;54:880-9.
8. Buckingham RB, Prince RK, Rodnan GP, Taylor F. Increased collagen acumulation in dermal fibroblasts cultures from patients with progressive systemic sclerosis (scleroderma). J Lab Clin Med. 1978;92:5-21.
9. Fleismajer R, Perlish JR, Krieg T, Timpl R. Variability in collagen and fibronectin sysnthesis by scleroderma fibroblasts in primary culture. J Invest Dermatol. 1981; 76:400-3.
10. Fleishmajer R, Dessau W, Timpl R, Krieg T, Luderschmidt C, Wiestner M. Immunofluorescence analysis of collagen, fibronectin and basement membrane protein in scleroderma skin. J Invest Dermatol. 1980;75:270-4.
11. Perlish J, Lemlich G, Fleischmajer R. Identification of Collagem fibrils in scleroderma skin. J Invest Dermatol. 1988;90:48-54.
12. Søndergaard K, Heickendorff L, Risteli L, Risteli J, Zachariae H, Stengaard-Pedersen K, et al. Increased levels of type I and III collagen and hyaluronan in scleroderma skin. Br J Dermatol. 1997;136:47-53.
13. Takasaki S, Fujiwara S, Shinkai H, Ooshima A. Human type VI collagen: purification from human subcutaneous fat tissue and an immunohistochemical study of morphea and systemic sclerosis. J Dermatol. 1995;22:480-5.
14. Rudnicka L, Varga J, Christiano AM, Iozzo RV, Jimenez AS, Uitto J. Elevated expression of type VII collagen in the skin of patients with systemic sclerosis. J Clin Invest. 1994; 93:1709-15.
15. Satomi E, Teodoro WR, Parra ER, Fernandes TD, Velosa AP, Capelozzi VL, et al. Changes in histoanatomical distribution of types I, III and V collagen promote adaptative remodeling in posterior tibial tendon rupture. Clinics. 2008; 63:9-14.
16. Teodoro WR, Velosa AP, Witzel SS, Garippo AL, Farhat C, Parra ER, et al. Architectural remodeling in lungs induced by type V collagen immunization: a preliminary morphologic model to study difuse conective tissue disease. Pathol Res Pract. 2004;200:681-91.
17. Bezerra MC, Teodoro WR, Oliveira CC, Velosa APP, Ogido LTI, Gauditano G, et al. Scleroderma-like remodelling induced by type V collagen. Arch Dermatol Res. 2006; 298:51-7.
18. Teodoro WR, Miron BG, Ogido LT, Velosa APP, Abatepaulo F, Capelozzi VL, et al. Synovial remodelling process induced by type V collagen immunization in rabbits. Pathol Res Pract. 2003;199:605-12.
19. Yoshinari NH, Teodoro WR, Ogido LTI, Velosa APP, Prizon CP, Miron B, et al. Modelo experimental de doenças difusas do tecido conjuntivo (DDTC) induzido por colágeno do tipo V. Rev Bras Reumatol. 2002;42:295-305.
20. Yoshinari NH, Callado MR, Velosa APP, Viana VTS, Goldeinstein-Schainberg C, Carrasco S, et al. Experimental Model of Scleroderma Induced in Rabbits. Arthritis Rheum. 2005; 52(9):s369.
21. Callado MR, Viana VS, Vendramini MB, Leon EP, Bueno C, Velosa AP, et al. Autoantibody profilie in the experimental model of scleroderma induced by type V human collagen. Immunology. 2007;122:38-46.
22. Montes GS. Structural biology of the fibers of the collagenous and elastic systems. Cell Biol Intermed. 1996;20:15-27.
23. SPSS Statistical software Version 10.0. SPSS Inc, Chicago; 2002.